The efficacy of human atrial natriuretic peptide in patients with renal dysfunction undergoing cardiac surgery.

Abstract

The results of this study suggest that in patients with renal dysfunction before cardiac surgery, continuous low-dose h-ANP therapy maintains renal function, preventing its deterioration.